Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Proteomic analysis of adverse outcomes in patients with acute coronary syndromes.

Dong SY, Sun XN, Zeng Q, Xu Y, Sun J, Ma LH.

Clin Chim Acta. 2013 Feb 1;416:60-6. doi: 10.1016/j.cca.2012.11.019. Epub 2012 Nov 27.

PMID:
23195030
2.

Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.

Lenderink T, Heeschen C, Fichtlscherer S, Dimmeler S, Hamm CW, Zeiher AM, Simoons ML, Boersma E; CAPTURE Investigators.

J Am Coll Cardiol. 2006 Jan 17;47(2):307-11.

3.

Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromes.

Novack V, Jotkowitz AB, Cutlip D, Amit G, Liebermann N, Porath A.

Postgrad Med J. 2008 Jan;84(987):50-5. doi: 10.1136/pgmj.2007.062018.

PMID:
18230752
6.

Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients.

Yan AT, Yan RT, Tan M, Chow CM, Fitchett D, Stanton E, Langer A, Goodman SG; Canadian Acute Coronary Syndromes (ACS) Registry Investigators.

Eur Heart J. 2004 Nov;25(22):2006-12.

7.

Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.

Napan S, Kashinath RC, Kadri S, Orig MN, Khadra S.

Coron Artery Dis. 2010 Aug;21(5):261-5. doi: 10.1097/MCA.0b013e32833aa6fa.

PMID:
20555264
9.

Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes.

McErlean ES, Deluca SA, van Lente F, Peacock F 4th, Rao JS, Balog CA, Nissen SE.

Am J Cardiol. 2000 Feb 15;85(4):421-6.

PMID:
10728944
10.

The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE).

Goodman SG, Steg PG, Eagle KA, Fox KA, López-Sendón J, Montalescot G, Budaj A, Kennelly BM, Gore JM, Allegrone J, Granger CB, Gurfinkel EP; GRACE Investigators.

Am Heart J. 2006 Mar;151(3):654-60.

PMID:
16504627
11.
12.

Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes.

Manenti ER, Bodanese LC, Camey SA, Polanczyk CA.

Clin Cardiol. 2006 Sep;29(9):405-10.

13.

Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes.

Newby LK, Roe MT, Chen AY, Ohman EM, Christenson RH, Pollack CV Jr, Hoekstra JW, Peacock WF, Harrington RA, Jesse RL, Gibler WB, Peterson ED; CRUSADE Investigators.

J Am Coll Cardiol. 2006 Jan 17;47(2):312-8.

14.

Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial.

Acharji S, Baber U, Mehran R, Fahy M, Kirtane AJ, Lansky AJ, Stone GW.

Circ Cardiovasc Interv. 2012 Apr;5(2):157-65. doi: 10.1161/CIRCINTERVENTIONS.111.963876. Epub 2012 Feb 21.

15.
16.

Interleukin-18: an independent predictor of cardiovascular events in patients with acute coronary syndrome after 6 months of follow-up.

Furtado MV, Rossini AP, Campani RB, Meotti C, Segatto M, Vietta G, Polanczyk CA.

Coron Artery Dis. 2009 Aug;20(5):327-331.

PMID:
19593889
17.

Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes.

Bonaca MP, Scirica BM, Sabatine MS, Jarolim P, Murphy SA, Chamberlin JS, Rhodes DW, Southwick PC, Braunwald E, Morrow DA.

J Am Coll Cardiol. 2012 Jul 24;60(4):332-8. doi: 10.1016/j.jacc.2012.04.023.

18.

Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.

Vikenes K, Andersen KS, Melberg T, Farstad M, Nordrehaug JE.

Am J Cardiol. 2010 Sep 15;106(6):780-6. doi: 10.1016/j.amjcard.2010.04.038. Epub 2010 Aug 1.

PMID:
20816117
20.

Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes.

Fuchs S, Gruberg L, Singh S, Stabile E, Duncan C, Wu H, Waksman R, Satler LF, Pichard AD, Kent KM, Kornowski R.

Am J Cardiol. 2001 Jul 15;88(2):129-33.

PMID:
11448408
Items per page

Supplemental Content

Write to the Help Desk